Retinitis Pigmentosa Market: How "CRISPR-in-a-Box" is...

added blog Health

2026-01-14 10:06:17 -

Retinitis Pigmentosa Market: How "CRISPR-in-a-Box" is Solving the Delivery Challenge?

In 2026, the application of CRISPR gene editing for Retinitis Pigmentosa has entered a new era with the development of safer, non-viral delivery systems. Historically, the use of viral vectors raised concerns about long-term safety and immune reactions, but 2026-gen "lipid nanoparticles" and "exosome-based carriers" are providing a way to deliver gene-editing tools directly to the retina...

0 Comments 0 Shares 191 Views 0 Reviews